75A50123C00037

MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	BARDA - ASPR / DAAPPO / BARDA DCMA
NAICS	541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC	AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$118.6M
Current contract value	$237.1M
Potential contract value / ceiling	$1.5B
Start date	Jul 31, 2023
Current end date	Jul 29, 2033
Potential end date	Jul 29, 2033
Latest award activity	Feb 5, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Feb 5, 2026	P00010	$0	THE PURPOSE OF THIS NO-COST MODIFICATION IS TO UPDATE SEVERAL ARTICLES.
Jul 8, 2025	P00009	$0	THE PURPOSE OF THIS NO-COST MODIFICATION IS TO ARTICLE G.11 NEGOTIATED INDIRECT COST RATE TO MATCH DOCUMENTATION FROM NIH DATED MARCH 19, 2025.
May 5, 2025	P00008	$0	THE PURPOSE OF THIS NO-COST MODIFICATION IS TO ARTICLE G.11 NEGOTIATED INDIRECT COST RATE BASED ON DOCUMENTATION FROM NIH DATED MARCH 19, 2025AND ARTICLE I.1 FAR 52.252-52, CLAUSES INCORPORATED BY REFERENCE (FEBRUARY 1998) IN ACCORDANCE WITH (I) FAR
Jan 10, 2025	P00007	$16.7M	THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 2/CLIN0003 AND UPDATE ARTICLE B.3 ESTIMATED COST PLUS FIXED FEE CLINS.
Dec 19, 2024	P00006	$0	THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLES B.1 BRIEF DESCRIPTION OF SUPPLIES AND SERVICES, B.5 ADVANCE UNDERSTANDINGS, C.1 STATEMENT OF WORK DATED DECEMBER 9, 2024, F.2 DELIVERIES, F.4 DELIVERABLES TO DELETE VENDOR MANAGED INVENTORY (VMI)
Aug 30, 2024	P00005	$41.9M	THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 1/CLIN0002 AND UPDATE ARTICLE B.3 ESTIMATED COST PLUS FIXED FEE CLINS.
Jun 24, 2024	P00004	$0	THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLES B.5. ADVANCE UNDERSTANDINGS (H) QUALITY AGREEMENT SHALL BE SUBMITTED FOR APPROVAL NO LATER THAN OCTOBER 31, 2024, F.2. VMI PLAN TO BE SUBMITTED FOR APPROVAL NO LATER THAN OCTOBER 31, 2024, F.3. S
Jun 5, 2024	P00003	$0	THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLE G.4 KEY PERSONNEL.
Apr 15, 2024	P00002	$0	THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLE C - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT ADDING ADDITIONAL WORK REQUESTED BY THE FDA AT NO ADDITIONAL COST TO THE GOVERNMENT, ARTICLE G.2 CONTRACTING OFFICER'S REPRESENTATIVE, AND ARTICL
Jan 10, 2024	P00001	$0	THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLE B.5. ADVANCE UNDERSTANDINGS (H) QUALITY AGREEMENT SHALL BE SUBMITTED FOR APPROVAL NO LATER THAN JUNE 28, 2024., ARTICLE F.2. VMI PLAN TO BE SUBMITTED FOR APPROVAL NO LATER THAN JUNE 28, 2024, AND
Jul 31, 2023	0	$60.0M	MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN

Estimated positioning window

Jul 29, 2032 – Jan 29, 2033

Recompete signal:

50/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 50/100. Available recorded signals: 45 points.

Contract end 2033-07-29 (2469 days from calculation): +5 points
121 historical awards in this buyer and category group: +15 points
11 recorded award transactions: +10 points
Latest award action: 2026-02-05: +5 points
Parent award identifier recorded: +0 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Check the stated set-aside against the solicitation and current certifications.
Review the award scope and buyer evidence before making a bid/no-bid decision.